BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Beam Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$24.19+0.72 (+3.07%)
Close on Oct 19, 2026
- Market cap
- $2.52B
- P/E (TTM)
- –
- Dividend yield
- –